Les médecines alternatives et complémentaires chez les patients cancéreux en cours de traitement à Marrakech, Maroc : étude prospective

Illias Tazi(Hôpital 20 Août), A. Tahri(Cadi Ayyad University), Hatim Nafil(Cadi Ayyad University), Mouna Khouchani(Cadi Ayyad University), Mhamed Harif(Institut d’Hématologie et d’Oncologie Pédiatrique), A. Elomrani(Cadi Ayyad University), Rhizlane Belbaraka(Cadi Ayyad University), L. Mahmal(Cadi Ayyad University), Z. Saadi(Cadi Ayyad University)
Bulletin de la Société de pathologie exotique
September 20, 2013
10.1007/s13149-013-0308-7
Cited by 20

Related Papers

Paediatric cancer in low-income and middle-income countries
|The Lancet Oncology|2013|432
The My Child Matters programme: effect of public–private partnerships on paediatric cancer care in low-income and middle-income countries
|The Lancet Oncology|2018|150
Treating Childhood Cancer in Low- and Middle-Income Countries
|Unknown|2015|146
Treatment of B‐cell lymphoma with LMB modified protocols in Africa—report of the French‐African Pediatric Oncology Group (GFAOP)
|Pediatric Blood & Cancer|2008|107
A framework to develop adapted treatment regimens to manage pediatric cancer in low‐ and middle‐income countries: The Pediatric Oncology in Developing Countries (PODC) Committee of the International Pediatric Oncology Society (SIOP)
|Pediatric Blood & Cancer|2017|100